Full-Time

Lead Bioinformatician

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$133.5k - $166.9kAnnually

Senior

Remote in USA

Category
Bioinformatics
Computational Biology
Genomics
Biology & Biotech
Required Skills
Python
R
Data Analysis
Requirements
  • Master’s degree in bioinformatics with 6 years post-graduate experience, or PhD with 3 years of post-graduate experience (preferred)
  • At least 4 years practical experience with data analysis tools such as Python or R
  • Expert knowledge of bioinformatics tools for NGS including all aspects of sequencing QC and secondary analyses including variant calling.
  • Strong programming and scripting experience in Python, R and shell.
  • Fluent in all aspects of exploratory data analysis and visualization for complex data sets and ability to distill observations to actionable recommendations.
  • Deep understanding of NGS workflows from sample extraction to sequencing.
  • Familiarity with cloud computing and workflow management tools such as SnakeMake, WDL or NextFlow.
  • Familiarity with typical approaches, best practices, and regulatory standards in CLIA product development design.
  • Ability to communicate effectively with wet lab groups and explain clearly technical bioinformatics concepts.
  • Ability to work independently while managing multiple objectives and timelines.
  • Desire to work in a fast-paced environment with potential for high impact in a small team.
Responsibilities
  • Collaborate with bench scientists to design and analyze experiments to evaluate novel assay technologies, and provide independent interpretation and recommendations for assay optimization.
  • Provide technical support for assays in production, including troubleshooting, QC monitoring and reporting out to lab operations, development and bioinformatics teams.
  • Develop algorithms and tools as necessary to support development of new products, including contributions to the bioinformatics pipeline.
  • Act as an internal technical consultant to other functional groups or their members by providing expert advice on bioinformatics methodology.
  • Work closely with interdisciplinary teams including assay, engineering, biostats, commercial and lab operations to support the development of new products.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through precise genetic insights.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

12%

1 year growth

27%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks